Merck KGaA’s AI Platform Architect On Redefining The Drug Discovery Process

 
• By Anju Ghangurde
  
Ashwini Ghogare, Head of AI and Automation in Drug Discovery at Merck KGaA’s life science business

More from Business

More from Digital Technologies